risks and benefits of glp 1 GLP-1 Medications Infographic GLP-1 Receptor Agonists: A Promising
Description
2020 global estimate and projected number of adults through 2035 with an overweight BMI [1]. Obesity is a significant independent risk factor contributing to numerous chronic conditions, including diabetes, hypertension, cardiovascular disease, and obstructive sleep apnea syndrome
Better digestive health
Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients some studies estimate roughly half or more to stop GLP-1s within a year and risk regaining the weight they lost
Describes general patterns observed in published research on the individual ingredients, not specific product claims
Early experience
My GLP-1 nutrition support is focused on the nutrition and lifestyle side of treatmentnot prescribing or adjusting medication
